User profiles for Hana Študentová
Hana ŠtudentováAssociate professor Verified email at fnol.cz Cited by 755 |
[HTML][HTML] Neopterin as a biomarker of immune response in cancer patients
…, LK Krčmová, L Javorská, H Študentová - Annals of …, 2017 - ncbi.nlm.nih.gov
With the advent of immunotherapy the topic of biomarkers of immune response is of high
interest. Along with the expression of programmed death ligand 1 (PD-L1) or tumor infiltrating …
interest. Along with the expression of programmed death ligand 1 (PD-L1) or tumor infiltrating …
[HTML][HTML] Plasma lipidomic profiles of kidney, breast and prostate cancer patients differ from healthy controls
…, K Hořejší, I Brabcová, D Vrána, H Študentová… - Scientific Reports, 2021 - nature.com
Early detection of cancer is one of the unmet needs in clinical medicine. Peripheral blood
analysis is a preferred method for efficient population screening, because blood collection is …
analysis is a preferred method for efficient population screening, because blood collection is …
Determination of one year stability of lipid plasma profile and comparison of blood collection tubes using UHPSFC/MS and HILIC-UHPLC/MS
…, R Jirásko, O Peterka, V Mužáková, H Študentová… - Analytica Chimica …, 2020 - Elsevier
Abstract Effects of blood collection tubes, the time period, the sample origin, and the method
used on the lipidomic profile are investigated by ultrahigh-performance supercritical fluid …
used on the lipidomic profile are investigated by ultrahigh-performance supercritical fluid …
Robust and high-throughput lipidomic quantitation of human blood samples using flow injection analysis with tandem mass spectrometry for clinical use
…, Z Vaňková, D Wolrab, R Hrstka, H Študentová… - Analytical and …, 2023 - Springer
Direct infusion of lipid extracts into the ion source of a mass spectrometer is a well-established
method for lipid analysis. In most cases, nanofluidic devices are used for sample …
method for lipid analysis. In most cases, nanofluidic devices are used for sample …
[HTML][HTML] Altered plasma, urine, and tissue profiles of sulfatides and sphingomyelins in patients with renal cell carcinoma
Simple Summary Renal cell carcinoma (RCC) is among the most common cancer types in
both men and women, and its early detection significantly improves survival. Minimally-…
both men and women, and its early detection significantly improves survival. Minimally-…
Intra-laboratory comparison of four analytical platforms for lipidomic quantitation using hydrophilic interaction liquid chromatography or supercritical fluid …
M Chocholoušková, D Wolrab, R Jirásko, H Študentová… - Talanta, 2021 - Elsevier
The lipidomic research is currently devoting considerable effort to the harmonization that
should enable the generation of comparable and accurate quantitative lipidomic data across …
should enable the generation of comparable and accurate quantitative lipidomic data across …
Lenvatinib for the treatment of kidney cancer
H Študentová, D Vitásková… - Expert Review of …, 2018 - Taylor & Francis
Introduction: Sequential administration of single targeted agents has evolved as the dominant
paradigm in advanced RCC treatment. Lenvatinib plus everolimus is the first combination …
paradigm in advanced RCC treatment. Lenvatinib plus everolimus is the first combination …
[HTML][HTML] Risk factors of atherosclerosis during systemic therapy targeting vascular endothelial growth factor
H Študentová, J Indráková, P Petrová… - Oncology …, 2016 - spandidos-publications.com
The aim of the present study was to examine the changes in intima‑media thickness (IMT) and
myocardial perfusion in association with other laboratory risk factors for atherosclerosis in …
myocardial perfusion in association with other laboratory risk factors for atherosclerosis in …
Pembrolizumab plus axitinib combination and the paradigm change in the treatment of advanced renal cell carcinoma
…, B Melichar, D Vitásková, H Študentová - Future …, 2021 - Future Medicine
Sequential administration of single targeted agents has been challenged as the dominant
treatment paradigm in patients with metastatic renal cell carcinoma by improved outcomes …
treatment paradigm in patients with metastatic renal cell carcinoma by improved outcomes …
Role of subcutaneous formulation of trastuzumab in the treatment of patients with HER2-positive breast cancer
B Melichar, H Študentová, H Kalábová… - Immunotherapy, 2014 - Future Medicine
Tumors in about 15% of patients with breast cancer overexpress HER2. Trastuzumab (Herceptin
® ; F. Hoffmann–La Roche, Basel, Switzerland) is a humanized monoclonal antibody …
® ; F. Hoffmann–La Roche, Basel, Switzerland) is a humanized monoclonal antibody …